GQG Partners’s Idexx Laboratories IDXX Stock Holding History

GQG Partners’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-931,886	Closed	-$407M	–	89
2023 Q3	$407M	Buy	+931,886	New	+$465M	0.94%	28
2020 Q3	–	Sell	-770	Closed	-$254K	–	69
2020 Q2	$254K	Buy	+770	New	+$223K	﹤0.01%	61

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

GQG Partners's IDXX Position: Q4 2023 in Review

GQG Partners sold out of Idexx Laboratories (IDXX) in Q4 2023, closing a stake of 931,886 shares — an estimated $407M sold.

GQG Partners first reported a position in IDXX in Q2 2020 and held it in 2 quarters. The position peaked at $407M in Q3 2023. 1,154 funds tracked by Wall St. Rank hold IDXX as of Q4 2023.

GQG Partners reported no remaining Idexx Laboratories position as of Q4 2023 after selling out during the quarter.
GQG Partners sold 931,886 Idexx Laboratories shares in Q4 2023, an estimated $407M.
GQG Partners first reported a position in Idexx Laboratories in Q2 2020 and held it in 2 quarters.
GQG Partners's Idexx Laboratories position peaked at $407M in Q3 2023.
1,154 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2023.

Based on GQG Partners's 13F filing for Q4 2023, filed 13 Feb 2024.